Evidence map›Paper›PMID 10570176›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo.

N Manjunath, P Shankar, B Stockton, P D Dubey, J Lieberman, U H von Andrian

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Intestinal CD4Nature communications · 2025
    Article
  3. Review
  4. Appearance of claudin-5Journal of neuroinflammation · 2021
    Article
  5. Dynamic chromatin regulatory landscape of human CAR T cell exhaustion.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Mouse Model for Human Vitiligo.Current protocols in immunology · 2019
    Article
  10. Article
  11. NeuroinvasiveFrontiers in immunology · 2018
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Real-time intravital imaging of cancer models.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2011
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

N ManjunathThe Center for Blood Research, Harvard Medical School, Boston, MA 02115, USA.
P Shankar
B Stockton
P D Dubey
J Lieberman
U H von Andrian
Harvard University · USTufts University · US

Funding

PREVENTION OF COLD INDUCED PLATELET STORAGE LESIONP01HL056949 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI WAGNER, DENISA D · 1996 to 2010
$26.2M
STUDIES OF NK AND T CELLS IN RELATION TO THE MAJOR HISTOCOMPATIBILITY COMPLEXP01HL029583 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI YUNIS, EDMOND J · 1985 to 2005
$9.8M
RECEPTOR TOPOGRAPHY IN MICROVASCULAR LEUKOCYTE ADHESIONR01HL054936 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI VON ANDRIAN, ULRICH H · 1996 to 2005
$2.2M
FUNCTION OF CD43 IN HEMATOPOIESIS AND T LYMPHOCYTESK08HL002881 · NHLBI · TUFTS MEDICAL CENTER · PI SWAMY, MANJUNATH NARASIMHA · 1994 to 1998
–
NHLBI NIH HHS HL02881NHLBI NIH HHS HL54936NHLBI NIH HHS HL56949NHLBI NIH HHS P01 HL029583NHLBI NIH HHS P01 HL056949NHLBI NIH HHS R01 HL054936
6 · The paper itself

Abstract

Antigen-specific effector T cells are prerequisite to immune protection, but because of the lack of effector cell-specific markers, their generation and differentiation has been difficult to study. We report that effector cells are highly enriched in a T cell subset that can be specifically identified in transgenic (T-GFP) mice expressing green fluorescent protein (GFP) under control of the murine CD4 promoter and proximal enhancer. Consistent with previous studies of these transcriptional control elements, GFP was strongly and specifically expressed in nearly all resting and short-term activated CD4(+) and CD8(+) T cells. However, when T-GFP mice were challenged with vaccinia virus, allogeneic tumor cells, or staphylococcal enterotoxin A, the cytotoxic and IFN-gamma-producing T cells lost GFP expression. Upon T cell receptor (TCR) ligation by alphaCD3, sorted GFP(+) cells fluxed calcium and proliferated vigorously. In contrast, GFP(-) effector cells showed a diminished calcium flux and did not proliferate. Instead, they underwent apoptosis unless supplied with exogenous IL-2. By reverse transcription-PCR analysis, the GFP(-) cells up-regulated the pro-apoptotic molecule, Fas-L, and down-regulated gene expression of the proximal TCR signaling molecule, CD3zeta, and c-jun, a component of the AP-1 transcription factor. Thus, differential regulation of TCR signaling may explain the divergent responses of naïve and effector T cells to antigen stimulation.

Indexed as

Models, ImmunologicalAnimalsAntigens, ViralCD3 ComplexCD4 AntigensCD4-Positive T-LymphocytesCell DifferentiationFas Ligand ProteinGene ExpressionGreen Fluorescent ProteinsLuminescent ProteinsMembrane GlycoproteinsMiceMice, TransgenicReceptors, Antigen, T-CellT-Lymphocytes, RegulatoryAntigens, ViralCD3 ComplexCD4 AntigensFas Ligand ProteinFasl protein, mouseGreen Fluorescent ProteinsLuminescent ProteinsMembrane GlycoproteinsReceptors, Antigen, T-Cell

Identifiers

PMID10570176
PMCPMC24168
OpenAlexW2055555686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.